Impact of cardiopulmonary exercise testing on patient selection for cardiac resynchronisation therapy

European Heart Journal, Supplement

Volumn 6, Issue D, 2004, Pages

  Lamp, Barbara ^a   Vogt, Jürgen ^a   Schmidt, Henning ^a   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiac resynchronisation therapy; Cardiopulmonary exercise testing; Heart failure; Left bundle branch block (LBBB)

Indexed keywords

CARBON DIOXIDE;

ACCURACY; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CORRELATION ANALYSIS; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HEART OUTPUT; HEART PACING; HEART TRANSPLANTATION; HUMAN; MORTALITY; OXYGEN CONSUMPTION; PATIENT CODING; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; QRS COMPLEX; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL; SYSTOLE;

EID: 3342933312     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehjsup.2004.05.020     Document Type: Review

References (39)

1. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60
2. Cleland J.G., Gemmell I., Khand A., et al. Is the prognosis of heart failure improving? Eur. J. Heart Fail. 1:1999;229-241
3. Recommendations for exercise testing in chronic heart failure patients. Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 2001;22:37-45
4. Opasich C., Pinna G.D., Bobbio M., et al. Peak exercise oxygen consumption in heart failure: toward efficient use in the individual patient. J. Am. Coll. Cardiol. 31:1998;766-775
5. Weber K., Janicki J. Cardiopulmonary exercise testing: physiologic principles and clinical applications. 1986;WB Saunders, Philadelphia
6. van den Broek S.A.J., van Veldhuisen D.J., de Graeff P.A., et al. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 70:1992;359-363
7. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786
8. Aaronson K.D., Mancini D.M. Is Percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J. Heart Lung Tranplant. 14:1995;981-989
9. Stevenson L.W., Steimle A.E., Fonarow G., et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J. Am. Coll. Cardiol. 25:1995;163-170
10. Gullestad L., Manhenke C., Aarsland T., et al. Effect of Metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial. Eur. J. Heart Fail. 3:2001;463-468
11. Aaronson K.D., Scheartz J.S., Chen T.M., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 95:1997;2660-2667
12. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 104:2001;2996-3007
13. Stelken A.M., Younis L.T., Jennison S.H., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J. Am. Coll. Cardiol. 27:1996;345-352
14. MacGowan G.A., Panzak G., Murali S. Exercise-related ventilatory abnormalities are more specific for functional impairment in chronic heart failure than reduction in peak exercise oxygen consumption. J. Heart Lung Transplant. 20:2001;1167-1173
15. Kleber F.X., Vietzke G., Mernecke K.D., et al. Impairment of ventilatory efficacy in heart failure - prognostic impact. Circulation. 101:2000;2803-2809
16. Chua T.P., Ponikowiski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J. Am. Coll. Cardiol. 29:1997;1585-1590
17. Rickli H., Kiowski W., Brehm M., et al. Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure. J. Am. Coll. Cardiol. 42:2003;116-122
18. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 132:1985;919-923
19. Lucas C., Stevenson L.W., Johnson W., et al. The 6-min walk and peak oxygen consumption in advanced heart failure: Aerobic capacity and survival. Am. Heart J. 138:1999;618-624
20. Isnard R., Pousset F., Chafirovskaia O., et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am. Heart J. 146:2003;729-735
21. Bonnet J.L., Ritter P., Pioger, et al. Measurement of minute ventilation with different DDDR pacemaker electrode configurations. Pacing Clin. Electrophysiol. 21:1998;4-10
22. Rickli H., Brunner-La Rocca H.P., Maccarter D.J., et al. Importance of AV synchronous pacing during low intensity exercise evaluated by oxygen kinetics. Pacing Clin. Electrophysiol. 23:2000;174-179
23. Auricchio A, Stellbrink C, Sack S et al. for the PATH-CHF Study Group. The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design and endpoints of a prospective, randomized multicenter study. Am J Cardiol 1999;83:130D-135D
24. Auricchio A, Ding J, Spinelli JC et al. for PATH-CHF Study Group. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol 2002;39:1163-9
25. Auricchio A, Stellbrink C, Butter C et al. on behalf of the Pacing Therapies in Congestive Heart Failure (PATH-CHF) II Study Group, Kramer A, Huvelle E, on behalf of the Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-16
26. Cazeau S, Leclercq P, Lavergne T et al. for the MUSTIC study group. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80
27. Leclercq C, Walker S, Linde C et al. on behalf of the MUSTIC study group. Comparative effects of permanent biventricular and right univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-7
28. Saxon LA, Boehmer JP, Hummel J et al. for the Ventak CHF and Vigor CHF Investigators. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999;83:120D-123D
29. Abraham WT, Fisher WG, Smith AL et al. for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53
30. Gras D., Leclercq C., Tang A.S., et al. Cardiac resynchronisation therapy in advanced heart failure: the multicenter Insync clinical study. Eur. J. Heart Fail. 4:2002;311-320
31. Bradley D.J., Bradley E.A., Baughman L.K., et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA. 289:2003;730-740
32. Bristow MR, Saxon LA, Boehmer J, et al. for the COMPANION Investigators. Cardiac Resynchronization Therapy (CRT) reduces hospitalizations, and CRT + an Implantable Defibrillator (CRT-D) reduces mortality in chronic heart failure: Preliminary results of the COMPANION Trial. In: 52nd Annual Scientific Session of the American College of Cardiology 2003, Late Breaking Clinical Trials
33. Gregoratos G., Abrams J., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices: summary article. J. Cardiovasc. Electrophysiol. 13:2002;1183-1199
34. Kloss M., Yu Y., Lamp B., et al. Sensitivity and specificity of using QRS duration to predict chronic benefit in heart failure patients with cardiac resynchronization therapy. J. Card. Failure. 8(Suppl. 4):2002;S74
35. Contak CD subanalysis: www.fda.org Contak CD CRT-D system Summary of safety and effectiveness
36. Zardini M,Tritto M, Forzani T et al. on behalf of the Investigators. The InSync Italian Registry: analysis of clinical outcome and considerations on the selection of candidates to left ventricular resynchronization. Eur Heart J Suppl 2000;2:J16-J22
37. Vogt J., Lamp B., Heintze J., et al. Pre-implant testing is the key to optimize resynchronization therapy. Circulation. 104:2001;II406-II417
38. Auricchio A., Kloss M., Trautmann S.I., et al. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. AM J. Cardiol. 89:2002;198-203
39. Stellbrink C., Auricchio A., Lemke B., et al. Positionspapier zur kardialen Resynchronisationstherapie. Z. Kardiol. 92:2003;96-103